Development begins on first artificial pancreas

Cholesterol has been identified as a trigger for the development of heart disease.

Researchers from the University of Oxford revealed that Lp(a), a type of cholesterol, has been linked with heart disease since the 1990s but only now have scientists been able to confirmed that it can cause it.

The research team hopes that the discovery could lead to the development of new treatments for the condition.

Lead author of the study Professor Hugh Watkins, said: "We all know about 'good' cholesterol and 'harmful' cholesterol, but this is a third class that we should pay attention to. Diet and exercise have little effect on Lp(a) levels but some existing drugs such as Niacin lower Lp(a) as well as LDL cholesterol."

He added: "Now that we know that Lp(a) is actually a cause of heart disease, testing whether treatments that lower it actually prevent heart attacks should become a priority."

The team's findings were published in the New England Journal of Medicine.

Comment on this page »


Latest news

AXA PPP healthcare win at UK Customer Experience awards 2015

David Mobbs retires as CEO of Nuffield Health

King's victorious at World Transplant Games

Development begins on first artificial pancreas
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information